Hipolito, Taciane Maira MagalhãesBastos, Guilherme Tadeu LemosBarbosa, Thulio Wliandon LemosSouza, Thiago Belarmino deCoelho, Luiz Felipe LeomilDias, Amanda Latercia TranchesRodríguez, Ihosvany CampsSantos, Marcelo Henrique dosDias, Danielle FerreiraFranco, Lucas LopardiCarvalho, Diogo Teixeira2019-04-222019-04-222018HIPOLITO, T. M. M. et al. Synthesis, activity, and docking studies of eugenol-based glucosides as new agents against Candida sp. Chemical Biology & Drug Design, v. 92, n. 2, p. 1514-1524, ago. 2018. Disponível em: <https://onlinelibrary.wiley.com/doi/full/10.1111/cbdd.13318>. Acesso em: 7 mar. 2019.1747-0285http://www.repositorio.ufop.br/handle/123456789/11078Seventeen new synthetic derivatives of eugenol (6, 8–15 and 8′‐15′) were planned following literature reports on antifungal activities of nitroeugenol and eugenol glucoside. The anti‐Candida activity of these compounds was investigated by in vitro assay, and the cytotoxicity evaluation was performed with the most active compounds. The peracetylated glucosides presented better biological results than their hydroxylated analogues. The glucoside 11, a 4‐nitrobenzamide, showed the best potency (MIC50 range 11.0–151.84 μm), the wider spectrum of action, and overall the best selectivity indexes, especially against C. tropicalis (~30) and C. krusei (~15). To investigate its possible mechanism of action, glucoside 11 was subjected to molecular docking studies with Candida sp. enzymes involved in ergosterol biosynthesis. Results have shown that the peracetyl glucosyl moiety and the 4‐nitrobenzamide group in 11 are effectively involved in its high affinity with the active site of squalene epoxidase.en-USrestritoAntifungalsMolecular dockingArtigo publicado em periodicohttps://onlinelibrary.wiley.com/doi/full/10.1111/cbdd.13318